Plus   Neg

EssilorLuxottica Posts H1 Loss, Revenues Down Amid Covid-19

French ophthalmic company EssilorLuxottica SA (ESLOF.PK,ESLOY.PK) Friday reported a net loss for the half year, with 29 percent decline in revenues during the period, impacted by the outbreak of Covid-19 pandemic.

The Group recorded a net loss of 400 million euros for the first half, as compared to a net profit 719 million euros in the first half of last year.

Net loss attributable to owners of the parent totaled 412 million euros versus net profit of 671 million euros last year. Loss per share was 0.94 euros versus profit per share of 1.53 euros last year.

On an adjusted basis, attributable profit was 7 million euros, compared to 1.047 billion euros last year. The results for the last year are restated.

EssilorLuxottica reported revenue of 6.230 billion euros for the first half, down 29 percent year-on-year at both current and constant exchange rates. These declines were attributed to the direct impact of Covid-19 related lockdowns across markets.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT